期刊文献+

两种脓毒症小鼠模型的比较 被引量:6

Comparison of two distinct animal models for polymicrobial sepsis in mice
原文传递
导出
摘要 目的比较两种不同脓毒症小鼠模型,探讨两种模型的差异,以及各自在脓毒症研究中的意义。方法取60只雄性BALB/c小鼠,随机分为假手术组、盲肠结扎穿刺(CLP)组和急性腹膜炎(AP)组,观察不同时间点各组的存活率,流式细胞术(FCM)检测脾脏Gr-1+/CD11b+细胞比例,ELISA检测外周血细胞因子水平。结果 AP组生存率在术后早期(术后1~2d)明显低于CLP组,但后期(术后2d以后)二者无统计学差异。CLP组脾脏Gr-1+/CD11b+细胞比例在术后第7天和第21天均高于AP组。外周血细胞因子(IL-6、IL-10)表达水平,AP组在术后6h和12h明显高于CLP组,但在术后24h二者无统计学差异。结论两种模型均较好地模拟了脓毒症的病理机制,但CLP更适合研究腹腔脓肿相关疾病引起的脓毒症,而AP模型则更类似于急性弥散性腹膜炎相关疾病所致的脓毒症。 Objective To investigate the difference between two distinct animal models for polymicrobial sepsis in mice as well as their difference in mimicking sepsis. Methods Sixty male BALB/c mice were randomly divided into three groups which were SHAM group, CLP group and AP group. The survival rate of several time points 'after surgery was observed in each group. The percentage of Gr-I +/CD11 b+ cells was determined by flow cytometry (FCM) ,and the serum eytokines(IL-6 and IL-10)was detected by ELISA. Results The survival rate of AP group was significantly lower than the survial rate of CLP in the early period( 1 d or 2 d after surgery) ,but the survial rate showed no difference between AP group and CLP group in the late period( beyond 2 d after surgery). The percentage of Gr-1 +/CDllb+ ceils in spleen of CLP group was higher than that of AP group on both the seventh day and the twentieth day after surgery. The serum IL-6 and serum IL-10 of AP group was significantly higher than that of CLP group at the 6 h and the 12 h after surgery, but no difference was showed at the 24 h after surgery between the AP group and the CLP group. Condusions Both the two animal models mimic the process of sepsis properly. However, the process of CLP model resembles peritoneal abscess while the process of AP model is similar to acute diffuse peritonitis.
出处 《中华临床医师杂志(电子版)》 CAS 2012年第8期21-23,共3页 Chinese Journal of Clinicians(Electronic Edition)
关键词 脓毒症 模型 动物 腹膜炎 盲肠结扎穿刺 Sepsis Model,animal Peritonitis Cecum ligation and puncture
  • 相关文献

参考文献10

  • 1Shiramizo SC,Marra AR,Duro MS. Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting[J].PLoS One,2011.e26790.doi:10.1371/journal.pone.0026790.
  • 2Rittirsch D,Huber-Lang MS,Flierl MA. Immunodesign of experimental sepsis by cecal ligation and puncture[J].Nature Protocols,2009.31-36.
  • 3Barrera G,Landoni V,Martire-Greco D. Model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsis[J].Infection and Immunity,2011.1280-1288.
  • 4Cuenca AG,Delano MJ,Kelly-Scumpia KM. Cecal ligation and puncture[J].Curr Protoc Immunol,2010.
  • 5Dejager L,Pinheiro I,Dejonckheere E. Cecal ligation and puncture:the gold standard model for polymicrobial sepsis[J].Trends in Microbiology,2011.198-208.
  • 6杜中涛,郁正亚.髓系抑制性细胞与脓毒症免疫抑制[J].中华临床医师杂志(电子版),2011,5(4):102-104. 被引量:2
  • 7Gabrilovich DI,Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system[J].Nature Reviews Immunology,2009,(3):162-174.doi:10.1038/nri2506.
  • 8Sander LE,Sackett SD,Dierssen U. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function[J].Journal of Experimental Medicine,2010.1453-1464.doi:10.1084/jem.20091474.
  • 9Traeger T,Koerner P,Kessler W. Colon ascendens stent peritonitis(CASP)——a standardized model for polymicrobial abdominal sepsis[J].J Vis Exp,2010,(46):pii:2299.
  • 10Peranzoni E,Zilio S,Marigo I. Myeloid-derived suppressor cell heterogeneity and subset definition[J].Current Opinion in Immunology,2010.238-244.doi:10.1016/j.coi.2010.01.021.

二级参考文献30

  • 1Pan PY,Wang GX,Yin B,et al.Reversion of immune tolerance in advanced malignancy; modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function.Blood,2008,111(1) -219-228.
  • 2Sinha P,Clements VK,Fulton AM,et al.Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.Cancer Res,2007,67(9) ;4507-4513.
  • 3Serafini P,Carbley R,Noonan KA,et al.High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.Cancer Res,2004,64(17):6337-6343.
  • 4Bunt SK,Yang L,Sinha P,et al.Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.Cancer Res,2007,67(20):10019-10026.
  • 5Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of sever sepsis in the United States;analysis of incidence,outcome,and associated costs of care.Crit Care Med,2001,29(7):1303-1310.
  • 6Strid J,Callard R,Strobel S.Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Thl)to Th2-type responses.Immunology,2006,119(1):27-35.
  • 7Jordan MB,Mills DM,Kappler J,et al.Promotion of B cell immune responses via an alum-induced myeloid cell population.Science,2004,304(5678):1808-1810.
  • 8Delano MJ,Scumpia PO,Weinstein JS,et al.MyD88-dependent expansion of an immature GR-1 (+) CDllb (+) population induces T cell suppression and Th2 polarization in sepsis.J Exp Med,2007,204(6):1463-1474.
  • 9Gabrilovich D.Mechanisms and functional significance of tumour-induced dendritic-ell defcects.Nat Rev Immunol,2004,4(12):` 941-952.
  • 10Pruitt JH,welborn MB,Edwards PD,et al.Increased soluble inteleukin-1 type 11 receptor concentration in postoperative patients and in patients with sepsis syndrome.Blood,1996,87 (8).3282-3288.

共引文献1

同被引文献60

  • 1王震平,刘东擘,梁华平.树突状细胞与脓毒症——两者的关系及新的治疗策略[J].免疫学杂志,2006,22(z1):33-36. 被引量:2
  • 2姚咏明.脓毒症动物模型的选择与评价[J].继续医学教育,2008,22(1):28-31. 被引量:13
  • 3朱雪琦,刘清泉,姚咏明.脓毒症动物模型制备方法的研究进展[J].中国危重病急救医学,2006,18(2):114-116. 被引量:29
  • 4汤耀卿,李磊.脓毒症动物模型制作方略及应用[J].中华实验外科杂志,2006,23(12):1433-1434. 被引量:59
  • 5Marshall JC,Charbonney E,Gonzalez PD.The immune system in critical illness.Clin Chest Med,2008,29:605-616.
  • 6Boomer JS,To K,Chang KC,et al.Immunosuppression in patients who die of sepsis and multiple organ failure.JAMA,2011,306:2594-2605.
  • 7Nascimento DC,Alves-Filho JC,Snego F,et al.Role of regulatory T cells in long-term immune dysfunction associated with severe sepsis.Crit Care Med,2010,38:1718-1725.
  • 8Kessel A,Bamberger E,Masalha M,et al.The role of T regulatory cells in human sepsis.J Autoimmun,2009,32:211-215.
  • 9Rittirsch D,Huber-Lang MS,Flierl MA,et al.Immunodesign of experimental sepsis by cecal ligation and puncture.Nature Protocols,2009,4:31-36.
  • 10Luan YY,Yao YM,Sheng ZY.Update on the Immunological Pathway of Negative Regulation in Acute Insults and Sepsis.J Interferon Cytokine Res.2012 Apr 17.

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部